• 제목/요약/키워드: C-erb-B2

검색결과 38건 처리시간 0.023초

구강 편평세포암에서 EGFR과 C-erb-B2 유전자 발현에 관한 면역조직화학적 연구 (IMMUNOHISTOCHEMICAL ANALYSIS OF EGFR AND C-ERB-B2 GENE EXPRESSION OF SQUAMOUS CELL CARCINOMA IN ORAL CAVITY)

  • 조원;조재식;이종원;김해송;박근재
    • 대한기관식도과학회지
    • /
    • 제2권2호
    • /
    • pp.200-212
    • /
    • 1996
  • The clinical staging systems for oral squamous cell carcinoma is limited as a prognostic indicatior because of different biological characteristics of cancer in this region and variable microenvironment depending on subsites, there have been study to determine prognosis by evaluating malignancy, that is the nature of tumor cells. Many studies have been tried to determine prognostic indicator in various malignancies for the evaluation of differentiation capacity and the expression of oncogene product. EGF make a role in cellular growth and differentiation and to be essential in cellular survival. EGFR is an intergral membrane protein, stimulate cellular differentiation and hormonal secretion, and has structural homology with V-erb-B transforming protein. Recent reports have demonstrated that EGFR is overexpressed in stomach, breast, vagina, dermis, head and neck, genitourinary and lung tumors, and possibly used as a tumor marker. In head and neck region, most of studies were mainly carried out on laryngeal squamous cell carcinoma. In the present study, immunohistochemical study for EGFR and C-erb-B2 gene in paraffin sections of 45 squamous cell carcinoma in oral cavity was performed to evaluate the presense of EGFR and C- erb-B2 gene in this lesion, to evaluate them as a prognostic indicator by analysing the correlation between these expression and subsites, primary stages, clinical stages, pathologic grades, neck node metastasis, recurrences and treatment results, and to determine relation between EGFR and C-erb-B2 gene.

  • PDF

수술을 시행한 비소세포 폐암 환자에서 EGFR, MMP-9 및 C-erbB-2의 발현과 환자 생존율과의 관계 (The Relationship between Expression of EGFR, MMP-9, and C-erbB-2 and Survival Time in Resected Non-Small Cell Lung Cancer)

  • 이승헌;정진용;이경주;이승현;김세중;하은실;김정하;이은주;허규영;정기환;정혜철;이승룡;이상엽;김제형;신철;심재정;인광호;강경호;유세화;김철환
    • Tuberculosis and Respiratory Diseases
    • /
    • 제59권3호
    • /
    • pp.286-297
    • /
    • 2005
  • 서 론 : 비소세포 폐암은 악성 종양 관련 사망의 중요한 원인 질환으로, 주요 병태생리 기전에 관여하는 EGFR, MMP-9 및 C-erbB-2의 발현 양상을 관찰 하는 것이 환자의 예후와 향후 치료 방향을 결정하는데 도움이 될 수 있다. 방 법 : 1995년 부터 2001년 까지 고려 대학교 의료원에 내원 후 원발성 비소세포 폐암 확진 후 외과절제술을 받은 81명 환자의 조직에 EGFR, MMP-9 및 C-erbB-2 면역 조직 화학 염색 및 정량화 후, 환자들의 특성 및 생존 기간과 함께, 조직 및 수술 병기에 따른 생물학적 표지자의 발현 양상을 후향적 고찰 하였다. 결 과 : 각 종양 조직 부위의 20%이상 염색되는 Grade 2 이상의 염색 양성률은, 편평상피세포암과 선암에서 EGFR은 75.0%와 63.4%, MMP-9은 43.3%와 43.9%, C-erbB-2는 23.3%와 22.0%를 보였다. 수술 병기가 I, II, IIIa 일때 EGFR 염색 양성률은 각각 75.0%, 66.7%, 76.9%, MMP-9은 41.7%, 47.6%, 46.2%, 그리고 C-erbB-2는 19.4%, 40.0%, 30.8%를 보였다. EGFR 양성군은 중앙 생존기간이 33.5개월로 EGFR 음성군의 71.8개월보다 유의한 불량한 예후를 나타냈다.(p<0.05). 그리고 MMP-9 양성군은 중앙 생존기간 35개월로 MMP-9 음성군의 65.3개월보다 불량한 생존 곡선의 양상을 보였으나 통계적 유의성은 없었다. 또한 C-erbB-2 양성군은 중앙 생존기간이 44.2개월, C-erbB-2 음성군은 58.4개월을 나타냈으나 통계적 유의한 차이는 없었다. EGFR과 MMP-9 동시 양성군은 전체 환자의 34.2%로서 중앙 생존기간이 26.9개월로 EGFR과 MMP-9 동시 음성군의 77.0개월보다 유의한 불량한 예후를 나타냈다(p<0.05) 결 론 : 비소세포 폐암 에서 EGFR의 양성군에서 음성군 보다 환자의 생존기간이 불량하였고, EGFR과 MMP-9의 동시 양성군에서 동시 음성군보다 생존기간이 불량하였다. C-erbB-2는 다른 생물학적 표지자에 비해서 낮은 염색 양성률을 나타냈으며 특이한 상관관계는 보이지 않았다.

Relation of Alcohol/Tobacco use with Metastasis, Hormonal (Estrogen and Progesterone) Receptor Status and c-erbB2 Protein in Mammary Ductal Carcinoma

  • Leon-Hernandez, Saul Renan;Padilla, Eleazar Lara;Algara, Alfredo Cortes;Rodriguez, Noemi Cardenas;Sanchez, Esau Floriano;Cruz, Jaime Lopez;Barradas, Cesar Miguel Mejia;Bandala, Cindy
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권14호
    • /
    • pp.5709-5714
    • /
    • 2014
  • Background: An association between alcohol/tobacco use and risk of metastasis in breast cancer has been clearly shown. Materials and Methods: The present study explored, in 48 samples of tissue from mammary ductal carcinoma (taken from Mexican women with an average age of $58.2{\pm}10.9$ years), the association of risk of metastasis with the status of hormonal receptors and the c-erbB2 protein (by immunohistochemistry) as well as clinical, histopathological and sociodemographic factors. Results: Of 48 patients, 41.6% (20/48) presented with metastasis, 43.8% were positive for the estrogen receptor (RE+), 31.3% for the progesterone receptor (RP+) and 47.7% for c-erbB2 (c-erbB2+). The following combinations were found: RE+/RP+/c-erbB2+ 8.3%, RE+/RP+ 22.9%, RE+/RP- 20.8%, RE-/RP+ 8.3%, RE-/RP-/c-erbB2- 22.9% and RE-/RP- 47.8%. There were 12 patients who used alcohol/tobacco, of which 91.6% did not present metastasis and 81.9% were RE-/RP-. Compared to the RE-/RP-/c-erbB2+, the RE+/RP+/c-erbB2+ group had a 15-fold greater risk for metastasis (95%CI, 0.9-228.8, p=0.05). The carriers of the double negative hormonal receptors had a 4.7 fold greater probability of being (or having been) smokers or drinkers (95%CI, 1.0-20.4, p = 0.03). Conclusions: There was a clear protective effect of using alcohol and/or tobacco, in the cases included in the present study of mammary ductal carcinoma, associated with double negative hormonal receptors. However, this association could be due to a protective factor not measured (Neyman bias) or to a bias inherent in the rate of hospitalization (Berkson fallacy). This question should be explored in a broad prospective longitudinal study.

알코올성 간 손상 조직에서 TGF-β1와 c-Myc, Erb-B2, Thymosin-β4 유전자 발현 융합 연구 (A study of Expression of TGF-β1, c-Myc, Erb-B2 and Thymosin-β4 Gene in Alcoholic Liver Damage Tissue.)

  • 김진수;최상기
    • 한국융합학회논문지
    • /
    • 제9권5호
    • /
    • pp.91-97
    • /
    • 2018
  • 본 연구는 25% 에탄올에 손상된 간조직에서 $TGF-{\beta}_1$와 c-Myc, Erb-B2, $Thymosin-{\beta}_4$ 유전자의 발현을 알아 보고자 실시 하였다. 실험군은 2군으로 나누어 25% 에탄올로 간 손상을 유발한 실험군과 정제수를 투여한 대조군으로 나누어 실험하였다. 검사 결과는 25% 에탄올를 투여 했던 실험군은 대조군에 비하여 $TGF-{\beta}_1$, c-Myc 및 $Thymosin-{\beta}_4$ 유전자의 발현 증가를 알 수 있었으며 Erb-B2 유전자는 뚜렷한 발현을 알 수 없었다. 또한 손상된 간 조직에서 헤마톡실린 에오진 염색을 통한 세포 손상을 관찰 할 수 있었다. 결론적으로 기존 임상에서 간 기능 관련 질병 예방과 질환 판정 시 혈청학적, 조직학적 검사 외에 $TGF-{\beta}_1$, c-Myc 및 $Thymosin-{\beta}_4$의 분자 진단 기법에 의한 유전자 발현 상태를 융합 검사함으로써 간 질환 판정의 보조 자료로 활용 될 수 있을 것으로 사료 된다.

편평상피 폐암 및 주위 정상조직에서 p53 및 c-erbB2 발현의 의의 (p53 and c-erbB2 as the Immunohistochemical Markers in Patients with Squamous Cell Carcinoma of the Lung)

  • 송창석;옥철호;정용석;장태원;정만홍;이재성;정혜진;허방;허만하
    • Tuberculosis and Respiratory Diseases
    • /
    • 제46권4호
    • /
    • pp.523-532
    • /
    • 1999
  • 연구배경: 폐암은 조기진단이 어려운 대표적인 종양이다. 최근 정상세포에서 악성조직으로 진행되는 각각의 과정에 대한 연구가 활발해 지면서 폐암의 발병과 진행에 관계하는 여러 유전자와 염색체의 이상들이 발견되고 있다. 이에 근거하여 폐암 중에서도 객담 세포진검사나 기관지내시경 검사 등으로 진단이 용이하고, 조기진단의 의의가 높은 편평상피 폐암을 대상으로 종양세포와 인접 정상 세포에서의 p53 및 c-erbB2의 발현율과 그 의의를 알아보았다. 대상 및 방법: 1995년 5월부터 1996년 11월까지 15개월 동안 편평상피 폐암으로 진단되어 폐절제술을 받은 25명의 환자를 대상으로 하여, 종양부위 및 그 인접 정상세포에서의 p53과 c-erbB2의 발현 여부를 면역조직화학적 검사법을 이용하여 조사하고 폐암의 병리적 병기 및 환자의 생존기간에 따른 발현율의 차이를 후향적으로 조사하였다. 결 과: 25명의 환자 중에서 병리적 병기 I, II가 각각 5명, IIIA가 8명, IIIB가 4명 및 IV가 3명이었다. 종양조직에서의 p53은 12명(48%), erb-B2는 3명(12%)에서 발현되었다. 인접 정상 기관지세포에서는 erb-B2는 3명(12%)에서 발현되었으나 p53은 한 예에서도 발현되지 않았다. 종양세포에서, 병기 II기 이하인 군 10명과 IIIA기 8명 및 IIIB와 IV기의 7명으로 나눠서 비교한 결과 p53이 발현된 경우는 각각 2예, 4예 및 6예로 병기가 진행될수록 발현율은 유의하게 높아졌다(p=0.009 by test of trend). 그러나 종양세포에서 이들의 발현여부에 따른 생존기간은 차이가 없었다. 결 론: p53은 정상 기관지세포에서는 전례에서 발현되지 않았으나 페종양조직에서는 발현율이 48%로 나왔으며, 발현율은 병기가 진행할수록 높아졌다. 따라서 기관지 생검조직에 p53을 이용한 면역조직화학적검사를 병행할 경우 편평상피세포 폐암의 경우 조기진단이나 병기판정에 도움이 될 것으로 추정되나 더 많은 환자를 대상으로 한 연구가 필요할 것으로 생각된다.

  • PDF

비강 및 부비동의 반전성 유두종에서 인유두종바이러스검출과 p53및 c-erbB-2의 발현 (Detection of Human Papillomavirus and Expression of p53, c-erbB-2 Protein in Inverted Papilloma of the Nasal Cavity and Paranasal Sinuses)

  • 조재식;백준;임상철;조연;윤제환;서덕중;박창수
    • 대한두경부종양학회지
    • /
    • 제17권2호
    • /
    • pp.162-168
    • /
    • 2001
  • Background: Inverted papilloma(IP) of the nasal cavity and paranasal sinuses is a benign neoplastic condition that can be associated with squamous cell carcinoma (SCC). Several studies have indicated an etiologic role for viruses in the development of inverted papilloma. And it is necessary to find out the significance of a biologic markers such as p53, c-erbB-2 to predict the malignant potential. The purposes of this study are to detect HPV in inverted papilloma of the nasal cavity and paranasal sinus, to examine role of HPV as an etiological agent, to examine the relationship between HPV subtype and malignant transformation of inverted papilloma, and to investigate the relation between expression rate of p53, c-erbB-2 and HPV in recurrent or malignant transformation cases. Material and Methods: Thirty two cases of inverted papilloma(IP) in the nasal cavity and paranasal sinuses were reviewed and classified into 3 groups; simple IP, IP with dysplasia group, IP with squamous cell carcinoma group. Paraffin embedded achival tissue was used in this study. The HPV was detected by in situ hybridzation (ISH) using HPV type 6/11, 16/18, 31/33/35 DNA probes. Expression of p53 and c-erbB-2 was examined by immunohistochemical staining. Results: 1) The HPV was detected in 6(19%) out of 32 cases. 2) The HPV 6/11 was dectected in 4 out of 21 cases of simple IP, HPV 16/18 in 1, HPV 31/33/35 in lout of 8 cases of IP with dysplasia respectively. 3) The positive expression of p53 was 13 cases out of 32 cases; 2 out of 21 cases of simple IP, all of 8 cases of IP with dysplasia and 3 cases of IP with squamous cell carcinoma 4) The positive expression of c-erbB-2 was in 24 out of 32 cases; 16 out of 21 cases of simple IP, 6 out of 8 cases of IP with dysplasia, 2 out of 3 cases of IP with squamous cell ca. 5) The recurrence of IP occurred in lout of 6 cases of positive for HPV, in 4 out of 26 cases negative for HPV. 6) The recurrence of IP occurred only in positive cases for p53. 7) The recurrence of IP occurred in 4(17%) out of 24 cases positive for c-erbB-2, in 1(13%) out of 8 cases negative for c-erbB-2. Conclusion: The p53 expression was associated with Inverted papillomas exhibiting evidence of malignant transformation. Also, there was a correlation between the p53 expression and recurrence.

  • PDF

Anti-metastasis Activity of Black Rice Anthocyanins Against Breast Cancer: Analyses Using an ErbB2 Positive Breast Cancer Cell Line and Tumoral Xenograft Model

  • Luo, Li-Ping;Han, Bin;Yu, Xiao-Ping;Chen, Xiang-Yan;Zhou, Jie;Chen, Wei;Zhu, Yan-Feng;Peng, Xiao-Li;Zou, Qiang;Li, Sui-Yan
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권15호
    • /
    • pp.6219-6225
    • /
    • 2014
  • Background: Increasing evidence from animal, epidemiological and clinical investigations suggest that dietary anthocyanins have potential to prevent chronic diseases, including cancers. It is also noteworthy that human epidermal growth factor receptor 2 (ErbB2) protein overexpression or ErbB2 gene amplification has been included as an indicator for metastasis and higher risk of recurrence for breast cancer. Materials and Methods: The present experiments investigated the anti-metastasis effects of black rice anthocyanins (BRACs) on ErbB2 positive breast cancer cells in vivo and in vitro. Results: Oral administration of BRACs (150 mg/kg/day) reduced transplanted tumor growth, inhibited pulmonary metastasis, and decreased lung tumor nodules in BALB/c nude mice bearing ErbB2 positive breast cancer cell MDA-MB-453 xenografts. The capacity for migration, adhesion, motility and invasion was also inhibited by BRACs in MDA-MB-453 cells in a concentration dependent manner, accompanied by decreased activity of a transfer promoting factor, urokinase-type plasminogen activator (u-PA). Conclusions: Together, our results indicated that BRACs possess anti-metastasis potential against ErbB2 positive human breast cancer cells in vivo and in vitro through inhibition of metastasis promoting molecules.

Expressions of Tumor-Related Proteins and $TGF-{\beta}1$ in Colon Cancer

  • ;김태근
    • 대한의생명과학회지
    • /
    • 제13권3호
    • /
    • pp.213-221
    • /
    • 2007
  • This study was designed to investigate the correlation between the expression rate of p53 and p21 proteins, c-erbB-2 oncoprotein and $TGF-{\beta}1$ and tumor prognostic factors in colon cancer including the tumor size, histological differentiation and Dukes' stage. The expression rate of p53 protein was 11.4% (4 cases) at well differentiation, 48.6% (17 cases) at moderately differentiation, and 17.1% (6 cases) at poorly differentiation. In other words, the poorer differentiation, the higher the expression rate of p53 protein (P<0.05). The expression rate of p21 protein was 17.1% (6 cases) at well differentiation, 40.0% (14 cases) at moderately differentiation, and 8.6% (3 cases) at poorly differentiation, indicating that, as the histological malignant degeneration progressed, the expression rate of p21 protein decreased distinctively (P<0.05). However, the correlation of the above mentioned proteins with tumor size and Dukes' stage was not recognized. The expression rate of c-cerbB-2 oncoprotein was 11.4% (4 cases) at well differentiation, 54.3% (19 cases) at moderately differentiation, and 17.1% (6 cases) at poorly differentiation, indicating that the poorer differentiation, the higher expression rate of c-erbB-2 oncoprotein (P<0.05). The expression rate of $TGF-{\beta}1$ was 17.1% (6 cases) at well differentiation, 48.6% (17 cases) at moderately differentiation, and 11.4% (4 cases) at poorly differentiation. As Dukes' stage progressed, the expression rate of $TGF-{\beta}1$ was 8.6% (3 cases) in stage A, 20.0% (7 cases) in stage B, 37.1 % (13 cases) in stage C, and 11.4% (4 cases) in stage D. There was a difference in expression rates between Dukes' stages (P<0.05). In 10 cases, p53 protein was positive while p21 protein was negative, and in 6 cases, p53 protein was negative whereas p21 was positive (P<0.05). Therefore, a statistically significant inverse correlation between the expression rate of p53 protein and that of p21 protein was observed. In conclusion, since there was a signigicant correlation between histological differentiation of colon cancer and the expressions of p53 and p21 proteins and c-erbB-2 oncoprotein, and between Dukes' stage and the expression of $TGF-{\beta}1$, it was conformed that the overexpression of p53 and p21 proteins, c-erbB-2 oncoprotein, and $TGF-{\beta}1$ is closely associated with the occurrence of colon cancer and its progress. Accordingly, this study may be greatly beneficial to the presumption of diagnosis, treatment and prognosis of colon cancer patients.

  • PDF

타액선 종양에서 종양증식 관련인자 발현에 관한 면역조직화학적 연구 (IMMUNOHISTOCHEMICAL STUDY ON EXPRESSION PATTERNS OF TUMOR GROWTH RELATED FACTORS IN SALIVARY GLAND TUMORS)

  • 김한석;김성민;박영욱
    • Maxillofacial Plastic and Reconstructive Surgery
    • /
    • 제29권5호
    • /
    • pp.405-416
    • /
    • 2007
  • Objective : Lots of papers have revealed that tumor growth related factors such as EGF, EGFR, c-erbB-2 play an important role in tumorigenesis and proliferation. These factors are found in most tumors of ectodermal origin. But, documentations of tumor growth related factors on salivary gland tumors were rare. Therefore, we determined expressions of tumor growth related factors; PCNA, p53, EGF, EGFR, cerbB2(HER-2), Maspin, DMBT-1, N-Ras in representative salivary gland tumors. Materials and methods : A few types of salivary tumors were examined by immunohistochemical assays. Each antibody was applied to specimens of tumors. Specimens were composed of 5 pleomorphic adenomas (PA), 3 mucoepidermoid carcinomas (MEC), 2 adenoid cystic carcinomas (ACC) and 2 squamous cell carcinomas (SCC) from 12 patients. One specimen was selected randomly as negative control. For evaluation of staining intensity, each stained sample was divided into 5 grade; no staining, obscure, weak staining, moderate staining, strong staining. Results : Strong expressions of PCNA were found in all tumors except of PA. EGF was expressed strongly in SCC, ACC sequently. But in both PA and MEC, EGF expression was weak. EGFR and c-erbB-2 expression showed similar patterns in all salivary gland tumor tissues. P53 showed weak expression generally in all salivary gland tumors. DMBT-1 was expressed in SCC rather than in ACC or in MEC. N-Ras showed weak expressions in all salivary gland tumors except of squamous cell carcinoma. Conclusion : Taken together, tumor growth related factors were expressed in salivay tumors as well as mucosal squamous cell carcinoma. Especially EGFR and c-erbB-2 could be candidates as diagnostic markers for estimating clinical grade of salivary gland tumors. But further studies with reliable methods will be needed to confirm the results of this study.

Overexpression of EGFR Protein in Bruneian Lung Cancer Patients

  • Han, Yu Hao;Hamid, Mas R.W. Abdul;Telisinghe, Pemasiri Upali;Hussin, Juniadah Binti Haji;Mabruk, Mohamed
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권1호
    • /
    • pp.233-237
    • /
    • 2015
  • Background: Lung cancer is the leading cause of cancer death in Brunei Darussalam, accounting for almost 20% of the total. The epidermal growth factor receptor (EGFR) is a member of the erbB family of tyrosine kinase receptor proteins, which includes c-erbb2(HER2/neu), erb-B3, and erb-B4. EGFR overexpression is found in a third of all epithelial cancers, often associated with a poor prognosis. Materials and Methods: Protein expression of EGFR in 27 cases of lung cancer tissue samples and 9 cases of normal lung tissue samples was evaluated using an immunohistochemical approach. Results: The results demonstrated significant increase and overexpression of EGFR in Bruneian lung cancer tissue samples in comparison to normal lung tissue. However, there was no significant relationship between clinicopathologic variables (age and sex) of patients and EGFR protein expression. Conclusions: EGFR is overexpressed in Bruneian lung cancer patient tissue samples in comparison to normal lung tissue samples. This may indicate that EGFR protein over expression plays an important role in the genesis of this type of cancer in Brunei Darussalam.